VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Viatris Inc. securities during the specified Class Period, highlighting potential investor compensation opportunities [1][2]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between August 8, 2024, and February 26, 2025, and aims to address misleading information provided by Viatris regarding the failed inspection of its Indore, India facility [1][4]. - Defendants allegedly downplayed the impact of an FDA Warning Letter, which restricted the shipment of eleven products from the Indore facility, referring to it as a "minor headwind" [4][6]. - The lawsuit claims that Viatris did not disclose critical information about the inspection timeline, remediation efforts, and the financial implications of the Warning Letter, leading to artificially inflated stock prices for investors [5][6]. Group 2: Investor Actions - Investors who purchased Viatris securities during the Class Period may be entitled to compensation without upfront costs through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for June 3, 2025 [3][8]. - It is noted that no class has been certified yet, and investors have the option to select their counsel or remain absent from the class [9].